Detalhe da pesquisa
1.
Increased macrophage phagocytic activity with TLR9 agonist conjugation of an anti- Borrelia burgdorferi monoclonal antibody.
Clin Immunol
; 246: 109180, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396013
2.
Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation.
Arch Pharm (Weinheim)
; 354(7): e2000393, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749032
3.
Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer.
J Proteome Res
; 17(10): 3574-3585, 2018 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30200768
4.
Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy.
Cell Rep Med
; 5(5): 101552, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729158
5.
Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics.
bioRxiv
; 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38249519
6.
PET Imaging of Innate Immune Activation Using 11C Radiotracers Targeting GPR84.
JACS Au
; 3(12): 3297-3310, 2023 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155640
7.
Designing Novel BCR-ABL Inhibitors for Chronic Myeloid Leukemia with Improved Cardiac Safety.
J Med Chem
; 65(16): 10898-10919, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944901
8.
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations.
Cancers (Basel)
; 14(24)2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551609
9.
Reengineering Ponatinib to Minimize Cardiovascular Toxicity.
Cancer Res
; 82(15): 2777-2791, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763671
10.
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer.
Cell Rep Med
; 3(2): 100502, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243415
11.
New Selective Inhibitors of ERG Positive Prostate Cancer: ERGi-USU-6 Salt Derivatives.
ACS Med Chem Lett
; 12(11): 1703-1709, 2021 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34790292
12.
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
Cell Chem Biol
; 28(8): 1206-1220.e6, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713600
13.
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
Sci Rep
; 9(1): 7178, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073181
14.
A ubiquitous metal, difficult to track: towards an understanding of the regulation of titanium(iv) in humans.
Metallomics
; 9(4): 346-356, 2017 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28164202
15.
Chlorido-containing ruthenium(II) and iridium(III) complexes as antimicrobial agents.
Dalton Trans
; 42(13): 4686-94, 2013 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23360972